iScience Surgical Inc.

Morgenthaler Ventures General Partner Robin Bellas admits to having some early concerns about the Transcend Medical Inc. , the first company to emerge from ForSight Labs LLC, the incubator backed by

A disease of aging, glaucoma is responsible for the first billion-dollar ophthalmic drug. Start-ups hope it will also become a billion-dollar device market. By Mary Stuart In the numerology of ophthal

In addition to their oversight role, boards at early-stage companies should be considered strategic assets of the firm. Developing a relation-based model built on a board/CEO partnership can increase